Vicapsys Life Sciences, Inc. (VICP) income statement
VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2024, quý kết thúc ngày Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)
Close on Oct 19, 2026Market cap $13.73MP/E –Yield –
Vicapsys Life Sciences, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2024
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2023
- 82.1%
Financial strength
- Current ratio
- 0.03
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 3.3%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?